# Santen

> Ophthalmic pharmaceuticals development and sales

Business model and tags: B2B, Publicly traded, Manufacturing, Pharma & life sciences, Medical devices, Parent company, Multi-site, International operations, Has production sites, Has in-house R&D

## About Santen

This specialized company in ophthalmology conducts research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices worldwide

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Osaka, Japan
- **Revenue**: €37.7M (FY2025, filed accounts, INPI)
- **SIREN**: [432584225](https://annuaire-entreprises.data.gouv.fr/entreprise/432584225)
- **Website**: [santen.com](https://www.santen.com/en)
- **LinkedIn**: [linkedin.com/company/santen](https://www.linkedin.com/company/santen)

## Jobs at Santen

- [Associate Director Marketing](https://www.linkedin.com/jobs/view/4461974803/) · Paris, Île-de-, France · Sep 4, 2026

[See all 1 openings](https://www.tamtam.ai/c/santen/jobs)

## Santen in the news

- [参天製薬、Copilot活用で4,000超のAIエージェントを創出](https://ai.watch.impress.co.jp/docs/news/2156284.html) · ai.watch.impress.co.jp · Nov 13, 2026
  Santen Pharmaceutical has rapidly integrated AI across its operations, creating over 4,000 AI agents with Microsoft Copilot, significantly boosting efficiency and developing specialized tools like "Field Coach" for medical representatives.
- [Has Santen Pharmaceutical (TSE:4536) Earned Its 56% Rise And Buyback Support?](https://finance.yahoo.com/markets/stocks/articles/santen-pharmaceutical-tse-4536-earned-031714777.html) · finance.yahoo.com · Nov 11, 2026
  The article questions if Santen Pharmaceutical's 56.1% share price increase over three years is justified by its earnings, highlighting a new share buyback program and a potentially undervalued P/E ratio.
- [Santen Pharmaceutical Co., Ltd. (SNPHY) stock price, news, quote and history](https://uk.finance.yahoo.com/quote/SNPHY/) · uk.finance.yahoo.com · Nov 11, 2026
  Santen Pharmaceutical Co., Ltd. researches, develops, produces, and markets ophthalmic pharmaceuticals and medical devices globally.

[See all 20 articles](https://www.tamtam.ai/c/santen/news)

## Santen at a glance

Santen is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Osaka, Japan.

Santen has 1,001–5,000 employees.

Santen's revenue is €37.7M (FY2025, filed accounts, INPI).

Santen's SIREN number is 432584225.

Santen is hiring: 1 recent open role, including Associate Director Marketing.

## Frequently asked questions about Santen

### What is Santen's revenue?

Santen's revenue is €37.7M (FY2025, filed accounts, INPI).

### How many employees does Santen have?

Santen has 1,001–5,000 employees.

### Where is Santen headquartered?

Santen is headquartered in Osaka, Japan.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/santen
